Borys D, Rupp R, Smulders R, Chichili GR, et al. Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial. Vaccine 2024 Feb 14:S0264-410X(24)00145-2. doi: 10.1016/j.vaccine.2024.
PMID: 38360475